Abstract
Tuberculosis is a neglected disease caused by Mycobacterium tuberculosis. Some evidence suggests its existence since thousands of years and today it still represents a public health problem. Current treatment presents serious problems such as adverse effects, high cost, long term, besides the emergence of resistant strains. Therefore the search for new antimicrobials is still in need. In this work we reviewed tuberculosis treatment as well as the synthesis of the current drugs and new synthetic derivatives that have been developed against M. tuberculosis. In this context we explored the medicinal chemistry and molecular modeling strategies as important tools to guide the rational design and synthesis of novel chemotherapeutic agents for use in tuberculosis.
Keywords: Antimicrobial, medicinal chemistry, Mycobaterium tuberculosis, resistance, topoisomerase inhibitors, tuberculosis.
Current Drug Therapy
Title:Tuberculosis, an Old Disease Lacking New Therapeutic Drugs
Volume: 8 Issue: 2
Author(s): Paula A. Abreu, Cid A. Medeiros, Julio C. Borges, Alice M.R. Bernardino, Carlos R. Rodrigues and Helena C. Castro
Affiliation:
Keywords: Antimicrobial, medicinal chemistry, Mycobaterium tuberculosis, resistance, topoisomerase inhibitors, tuberculosis.
Abstract: Tuberculosis is a neglected disease caused by Mycobacterium tuberculosis. Some evidence suggests its existence since thousands of years and today it still represents a public health problem. Current treatment presents serious problems such as adverse effects, high cost, long term, besides the emergence of resistant strains. Therefore the search for new antimicrobials is still in need. In this work we reviewed tuberculosis treatment as well as the synthesis of the current drugs and new synthetic derivatives that have been developed against M. tuberculosis. In this context we explored the medicinal chemistry and molecular modeling strategies as important tools to guide the rational design and synthesis of novel chemotherapeutic agents for use in tuberculosis.
Export Options
About this article
Cite this article as:
Abreu A. Paula, Medeiros A. Cid, Borges C. Julio, Bernardino M.R. Alice, Rodrigues R. Carlos and Castro C. Helena, Tuberculosis, an Old Disease Lacking New Therapeutic Drugs, Current Drug Therapy 2013; 8 (2) . https://dx.doi.org/10.2174/1574885511308020003
DOI https://dx.doi.org/10.2174/1574885511308020003 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biologically Active 4-Thiazolidinones: A Review of QSAR Studies and QSAR Modeling of Antitumor Activity
Current Topics in Medicinal Chemistry Antisense Antibiotics: A Brief Review of Novel Target Discovery and Delivery
Current Drug Discovery Technologies Induction of Autophagic Cell Death in Apoptosis-resistant Pancreatic Cancer Cells using Benzo[α]phenoxazines Derivatives, 10-methyl-benzo[α]phenoxazine-5-one and benzo[α]phenoxazine-5-one
Anti-Cancer Agents in Medicinal Chemistry Fighting Diabetes: Lessons from Xenotransplantation and Nanomedicine
Current Pharmaceutical Design Burkholderia mallei and Burkholderia pseudomallei: The Causative Micro-organisms of Glanders and Melioidosis
Recent Patents on Anti-Infective Drug Discovery HIV Infection Late Detection in AIDS Patients of an European City with Increased Immigration Since Mid 1990s
Current HIV Research Maternal Vitamin D Status and Development of Asthma and Allergy in Early Childhood
Mini-Reviews in Medicinal Chemistry A Rational Approach to Identify Inhibitors of Mycobacterium tuberculosis Enoyl Acyl Carrier Protein Reductase
Current Pharmaceutical Design Lessons from Seven Decades of Antituberculosis Drug Discovery
Current Topics in Medicinal Chemistry Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
Current Drug Targets Potential Therapeutic Agents from the Red Sea Organisms
Medicinal Chemistry Antimalarial Drugs and their Useful Therapeutic Lives: Rational Drug Design Lessons from Pleiotropic Action of Quinolines and Artemisinins
Current Drug Discovery Technologies Bronchoscopy in Children for Research with Questionable Indications: An Overview of Russian Patents and Publications
Recent Patents on Drug Delivery & Formulation Transition-State-Guided Drug Design for Treatment of Parasitic Neglected Tropical Diseases
Current Medicinal Chemistry On the Paradigm Shift Towards Multitarget Selective Drug Design
Current Computer-Aided Drug Design Patent Selection
Recent Patents on Biotechnology Synthesis and SAR Study of Simple Aryl Oximes and Nitrofuranyl Derivatives with Potent Activity Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Solvent-free Synthesis of Phthalazine-2(1H)-carboxamide Derivatives Using K-10 Clay Under Microwave Irradiation
Letters in Organic Chemistry Human Tuberculosis II. M. tuberculosis Mechanisms of Genetic and Phenotypic Resistance to Anti-Tuberculosis Drugs
Current Medicinal Chemistry Nitric Oxide and the Regulation of Apoptosis in Tumour Cells
Current Pharmaceutical Design